Jul 12, 2021
Vivpro Announces New Appointment To Board Of Advisors: Dr. Ajaz Hussain
Vivpro Corporation announced today that it has appointed Dr. Ajaz Hussain, a world renowned leader in the life-sciences industry with unique experience across academia, US FDA, and industry.
”We are excited to welcome Dr. Hussain to our esteemed advisory board,” said Dr. Joga Gobburu, President Vivpro Corporation. ”Ajaz has a unique perspective based on his vast regulatory and industry experience. We look forward to working with Ajaz to further the mission to re-imagine drug development. Ajaz is a founding member of the Vivpro Advisory Board. Vivpro Advisory Board is a critical step in our journey as we enter a new stage of product growth, we would like to work with passionate individuals like Ajaz to validate and guide our niche market strategy and customer value.”
This is one of several appointments that will be announced over the next few weeks. Vivpro will regularly evaluate the membership to ensure it includes diverse skills, experience and perspective necessary to drive growth for all Vivpro customers.
”I am excited to join the Vivpro Advisory Board. The Vivpro mission aligns with my vision and belief as we try to solve the mysteries in life sciences and add value to fellow beings in this and following generations,” said Dr. Ajaz Hussain.
About Dr. Ajaz Hussain
Dr. Ajaz Hussain leverages his remarkably unique experience to advise several life-science corporations. His careers span across academia, US FDA, and industry; serving as the Presidentof the National Institute for Pharmaceutical Technology and Education, the Deputy Director, Office of Pharmaceutical Science, CDER, FDA, Global Head Biopharmaceutical Development at Sandoz, Chief Scientific Officer and VP at Philip Morris International, and President Biotechnology at Wockhardt. He trained as a pharmacist in Mumbai and received his doctoral degree from the University of Cincinnati. He is a Fellow of AAPS and the Swiss Society of Pharmaceutical Science.
